Picard Medical, Inc.

Picard Medical, Inc.

PMI
Picard Medical, Inc.US flagNew York Stock Exchange Arca
4.56
USD
+0.07
- -
9.39MMarket Cap

Total Valuation

Picard Medical, Inc. carries a market capitalization of 9.39M, placing it among publicly traded companies globally. Its enterprise value stands at 18.34M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.39M
Enterprise Value18.34M

Share Statistics

Picard Medical, Inc. currently has 2.05M shares outstanding.

Shares Outstanding2.05M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.92, and the price-to-book ratio stands at 9.79.

PE RatioN/A
PS Ratio1.92
PB Ratio9.79
P/TBV Ratio26.42
P/FCF Ratio-0.75
P/OCF Ratio-0.75

Enterprise Valuation

EV / Sales2.91
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Picard Medical, Inc. maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 91.96, indicating elevated leverage, while an interest coverage ratio of -6.03 demonstrates limited ability to service its debt obligations.

Current Ratio1.02
Quick Ratio0.09
Debt / Equity91.96
Debt / EBITDA-0.10
Interest Coverage-6.03

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-268.26
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.79

Taxes

Income Tax11,000.00
Effective Tax RateN/A

Stock Price Statistics

Picard Medical, Inc.'s stock has declined approximately -98.63063% over the past 52 weeks. The 50-day moving average sits at 5.75, while the 200-day moving average is 47.36.

Beta (5Y)N/A
52-Week Price Change-98.63063%
50-Day Moving Average5.75
200-Day Moving Average47.36
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Picard Medical, Inc. generated 6.30M in revenue and converted that into -27.99M in net income, yielding earnings per share of -18.94. EBITDA reached -15.10M, while operating income came in at -15.63M.

Revenue6.30M
Gross Profit1.17M
Operating Income-15.63M
Pretax Income-27.98M
Net Income-27.99M
EBITDA-15.10M
EBIT-15.63M
Earnings Per Share (EPS)-18.94

Balance Sheet

Picard Medical, Inc. holds 38,000.00 in cash and equivalents against 1.58M in total debt, resulting in a net debt position of 1.23M. Total book value stands at 1.72M, with working capital of 141,000.00 providing operational flexibility.

Cash & Cash Equivalents38,000.00
Total Debt1.58M
Net Debt1.23M
Equity (Book Value)1.72M
Book Value Per Share0.84
Working Capital141,000.00

Cash Flow

Picard Medical, Inc. produced -16.04M in operating cash flow over the past twelve months. After subtracting -26,000.00 in capital expenditures, free cash flow totaled -16.07M - equivalent to -10.87 per share.

Operating Cash Flow-16.04M
Capital Expenditures-26,000.00
Free Cash Flow-16.07M
FCF Per Share-10.87

Margins

Picard Medical, Inc. operates with a gross margin of 18.60, reflecting its pricing power and cost economics. The operating margin of -248.10 and net profit margin of -444.33 provide insight into operational efficiency.

Gross Margin18.60
Operating Margin-248.10
Pretax Margin-444.16
Profit Margin-444.33
EBITDA Margin-239.67

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-93.39
FCF Yield-132.49

Stock Splits

Picard Medical, Inc.'s most recent stock split took place on August 3, 2026 with a 50:1 split ratio.

Last Split Date8/3/2026
Split Ratio50:1

Scores

Picard Medical, Inc. posts an Altman Z-Score of -19.83, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-19.83